Global Viral Vectors for Non-human Primates Market Size, Share, and COVID-19 Impact Analysis, By Vector Type (Adenoviral Vectors, Adeno-associated Vectors, Retroviral Vectors, Lentiviral Vectors, and Others), By Type of Non-human Primates (Marmosets, Rhesus Macaques, Cynomolgus Monkey, and Others), By Application (Gene Therapy and Vaccine Research), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Oct 2025
REPORT ID SI15926
PAGES 245
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Vector Type
      2. Market Attractiveness Analysis, By Type of Non-human Primates
      3. Market Attractiveness Analysis, By Application
      4. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing need for gene therapies, sophisticated biomedical research, and enhanced applications of NHP models
    3. Restraints
      1.  High expenses, rigorous regulations, ethical concerns, and biosafety risks
    4. Opportunities
      1.  Advancements like AAV and Adenovirus technologies, and increasing use in complex disease models like neurological disorders
    5. Challenges
      1. Toxicity of viral vectors
  6. Global Viral Vectors for Non-human Primates Market Analysis and Projection, By Vector Type
    1. Segment Overview
    2. Adenoviral Vectors
    3. Adeno-associated Vectors
    4. Retroviral Vectors
    5. Lentiviral Vectors
    6. Others
  7. Global Viral Vectors for Non-human Primates Market Analysis and Projection, By Type of Non-human Primates
    1. Segment Overview
    2. Marmosets
    3. Rhesus Macaques
    4. Cynomolgus Monkey
    5. Others
  8. Global Viral Vectors for Non-human Primates Market Analysis and Projection, By Application
    1. Segment Overview
    2. Gene Therapy
    3. Vaccine Research
  9. Global Viral Vectors for Non-human Primates Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Viral Vectors for Non-human Primates Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Viral Vectors for Non-human Primates Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Lonza Group AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   REGENXBIO Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Oxford Biomedica 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Merck KGaA 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   4D Molecular Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Biovian Oy
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Thermo Fisher Scientific Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. CRISPR Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Barinthus Biotherapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Genezen 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Andelyn Biosciences
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Fujifilm Diosynth Biotechnologies
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Tables

  1. Global Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  2. Global Adenoviral Vectors, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  3. Global Adeno-associated Vectors, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  4. Global Retroviral Vectors, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  5. Global Lentiviral Vectors, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  6. Global Others, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  7. Global Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  8. Global Marmosets, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  9. Global Rhesus Macaques, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  10. Global Cynomolgus Monkey, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  11. Global Others, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  12. Global Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  13. Global Gene Therapy, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  14. Global Vaccine Research, Viral Vectors for Non-human Primates Market, By Region, 2024-2035(USD Billion)
  15. North America Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  16. North America Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  17. North America Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  18. U.S.  Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  19. U.S.  Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  20. U.S.  Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  21. Canada Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  22. Canada Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  23. Canada Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  24. Mexico Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  25. Mexico Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  26. Mexico Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  27. Europe Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  28. Europe Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  29. Europe Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  30. Germany Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  31. Germany Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  32. Germany Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  33. France Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  34. France Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  35. France Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  36. U.K.  Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  37. U.K.  Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  38. U.K.  Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  39. Italy Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  40. Italy Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  41. Italy Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  42. Spain Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  43. Spain Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  44. Spain Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  45. Asia Pacific Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  46. Asia Pacific Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  47. Asia Pacific Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  48. Japan Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  49. Japan Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  50. Japan Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  51. China Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  52. China Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  53. China Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  54. India Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  55. India Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  56. India Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  57. South America Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  58. South America Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  59. South America Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  60. Brazil Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  61. Brazil Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  62. Brazil Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  63. The Middle East and Africa Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD   Billion)
  64. The Middle East and Africa Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD   Billion)
  65. The Middle East and Africa Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  66. UAE Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  67. UAE Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  68. UAE Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)
  69. South Africa Viral Vectors for Non-human Primates Market, By Vector Type, 2024-2035(USD Billion)
  70. South Africa Viral Vectors for Non-human Primates Market, By Type of Non-human Primates, 2024-2035(USD Billion)
  71. South Africa Viral Vectors for Non-human Primates Market, By Application, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Viral Vectors for Non-human Primates Market Segmentation
  2. Viral Vectors for Non-human Primates Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Viral Vectors for Non-human Primates Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining Power of Buyers
  13. Moderate Bargaining Power of Suppliers
  14. Moderate Bargaining Power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Viral Vectors for Non-human Primates Market
  20. Viral Vectors for Non-human Primates Market Segmentation, By Vector Type
  21. Viral Vectors for Non-human Primates Market For Adenoviral Vectors, By Region, 2024-2035 ($ Billion)
  22.  Viral Vectors for Non-human Primates Market For Adeno-associated Vectors, By Region, 2024-2035 ($ Billion)
  23. Viral Vectors for Non-human Primates Market For Retroviral Vectors, By Region, 2024-2035 ($ Billion)
  24. Viral Vectors for Non-human Primates Market For Lentiviral Vectors, By Region, 2024-2035 ($ Billion)
  25. Viral Vectors for Non-human Primates Market For Others, By Region, 2024-2035 ($ Billion)
  26.  Viral Vectors for Non-human Primates Market Segmentation, By Type of Non-human Primates
  27.  Viral Vectors for Non-human Primates Market For Marmosets, By Region, 2024-2035 ($ Billion)
  28.  Viral Vectors for Non-human Primates Market For Rhesus Macaques, By Region, 2024-2035 ($ Billion)
  29. Viral Vectors for Non-human Primates Market For Cynomolgus Monkey, By Region, 2024-2035 ($ Billion)
  30. Viral Vectors for Non-human Primates Market For Others, By Region, 2024-2035 ($ Billion)
  31. Viral Vectors for Non-human Primates Market Segmentation, By Application
  32. Viral Vectors for Non-human Primates Market For Gene Therapy, By Region, 2024-2035 ($ Billion)
  33. Viral Vectors for Non-human Primates Market For Vaccine Research, By Region, 2024-2035 ($ Billion)
  34. Lonza Group AG: Net Sales, 2024-2035 ($ Billion)
  35. Lonza Group AG: Revenue Share, By Segment, 2024 (%)
  36. Lonza Group AG: Revenue Share, By Region, 2024 (%)
  37. REGENXBIO Inc.: Net Sales, 2024-2035 ($ Billion)
  38. REGENXBIO Inc.: Revenue Share, By Segment, 2024 (%)
  39. REGENXBIO Inc.: Revenue Share, By Region, 2024 (%)
  40. Oxford Biomedica: Net Sales, 2024-2035 ($ Billion)
  41. Oxford Biomedica: Revenue Share, By Segment, 2024 (%)
  42. Oxford Biomedica: Revenue Share, By Region, 2024 (%)
  43. Merck KGaA: Net Sales, 2024-2035 ($ Billion)
  44. Merck KGaA: Revenue Share, By Segment, 2024 (%)
  45. Merck KGaA: Revenue Share, By Region, 2024 (%)
  46. 4D Molecular Therapeutics: Net Sales, 2024-2035 ($ Billion)
  47. 4D Molecular Therapeutics: Revenue Share, By Segment, 2024 (%)
  48. 4D Molecular Therapeutics: Revenue Share, By Region, 2024 (%)
  49. Biovian Oy: Net Sales, 2024-2035 ($ Billion)
  50. Biovian Oy: Revenue Share, By Segment, 2024 (%)
  51. Biovian Oy: Revenue Share, By Region, 2024 (%)
  52. Thermo Fisher Scientific Inc.: Net Sales, 2024-2035 ($ Billion)
  53. Thermo Fisher Scientific Inc.: Revenue Share, By Segment, 2024 (%)
  54. Thermo Fisher Scientific Inc.: Revenue Share, By Region, 2024 (%)
  55. CRISPR Therapeutics: Net Sales, 2024-2035 ($ Billion)
  56. CRISPR Therapeutics: Revenue Share, By Segment, 2024 (%)
  57. CRISPR Therapeutics: Revenue Share, By Region, 2024 (%)
  58. Barinthus Biotherapeutics.: Net Sales, 2024-2035 ($ Billion)
  59. Barinthus Biotherapeutics: Revenue Share, By Segment, 2024 (%)
  60. Barinthus Biotherapeutics: Revenue Share, By Region, 2024 (%)
  61. Genezen: Net Sales, 2024-2035 ($ Billion)
  62. Genezen: Revenue Share, By Segment, 2024 (%)
  63. Genezen: Revenue Share, By Region, 2024 (%)
  64. Andelyn Biosciences: Net Sales, 2024-2035 ($ Billion)
  65. Andelyn Biosciences: Revenue Share, By Segment, 2024 (%)
  66. Andelyn Biosciences: Revenue Share, By Region, 2024 (%)
  67. Fujifilm Diosynth Biotechnologies: Net Sales, 2024-2035 ($ Billion)
  68. Fujifilm Diosynth Biotechnologies: Revenue Share, By Segment, 2024 (%)
  69. Fujifilm Diosynth Biotechnologies: Revenue Share, By Region, 2024 (%)
  70. Others: Net Sales, 2024-2035 ($ Billion)
  71. Others: Revenue Share, By Segment, 2024 (%)
  72. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:122
Pages:245
Countries covered:17
Companies covered::20
Forecast CAGR:10.36%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies